Healthcare -
Biotechnology - NASDAQ - US
$ 585.315
-0.297 %
$ 62.6 B
Market Cap
14.64
P/E
REGN - OTHER LONG-TERM ASSETS
Other Long-term Assets REGN - Regeneron Pharmaceuticals, Inc.
10 B
LAST VALUE
103.82%
2 YEAR CAGR
79.95%
5 YEAR CAGR
63.28%
10 YEAR CAGR